Skip to Content

Bioqual Inc BIOQ

Morningstar Rating
$72.50 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BIOQ is trading at a 164% premium.
Price
$72.19
Fair Value
$75.19
Uncertainty
Extreme
1-Star Price
$336.53
5-Star Price
$52.74
Economic Moat
Zwqwc
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BIOQ is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$72.50
Day Range
$72.5072.50
52-Week Range
$59.0080.00
Bid/Ask
$72.50 / $79.00
Market Cap
$64.85 Mil
Volume/Avg
151 / 474

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
0.69%
Dividend Yield (Forward)
0.69%
Total Yield
0.69%

Company Profile

Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Growth
Total Number of Employees
117

Valuation

Metric
BIOQ
Price/Earnings (Normalized)
Price/Book Value
1.68
Price/Sales
Price/Cash Flow
Price/Earnings
BIOQ

Financial Strength

Metric
BIOQ
Quick Ratio
3.75
Current Ratio
4.14
Interest Coverage
107.19
Quick Ratio
BIOQ

Profitability

Metric
BIOQ
Return on Assets (Normalized)
14.91%
Return on Equity (Normalized)
17.85%
Return on Invested Capital (Normalized)
17.51%
Return on Assets
BIOQ
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
XkpkyhxrmcYps$206.4 Bil
Danaher Corp
DHR
LhfhrbbqdHffkdnh$181.3 Bil
IQVIA Holdings Inc
IQV
TlgktpplcXppnlzt$41.0 Bil
IDEXX Laboratories Inc
IDXX
HthddhbnqjFtqghb$38.9 Bil
Agilent Technologies Inc
A
ZxpgzffmcVkm$38.5 Bil
Mettler-Toledo International Inc
MTD
SpstzmvxBfwxx$29.0 Bil
Icon PLC
ICLR
JsdghqwvgPwtpnx$27.1 Bil
Illumina Inc
ILMN
GxzpwxcLcsdhw$18.4 Bil
Waters Corp
WAT
FprkqjssQjr$18.3 Bil
Labcorp Holdings Inc
LH
XvywrknrfRnmjckh$18.1 Bil

Sponsor Center